Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment
- 1 September 1995
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 133 (3), 494-496
- https://doi.org/10.1111/j.1365-2133.1995.tb02691.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tacrolimus ointment for atopic dermatitisThe Lancet, 1994
- Inhibition of contact allergy reactions by topical FK506The Lancet, 1992
- Cyclosporin ointment for psoriasis and atopic dermatitisThe Lancet, 1992
- Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisThe Lancet, 1991
- Placebo-controlled study of psoriasis patients treated topically with a 10% cyclosporine gelJournal of the American Academy of Dermatology, 1990
- (5) Topical cyclosporin A in alopecia totalis: failure of therapeutic effect due to lack of penetrationBritish Journal of Dermatology, 1989
- Topical cyclosporins in psoriasisJournal of the American Academy of Dermatology, 1988
- Topical Ciclosporin for Psoriasis: In vitro Skin Penetration and Clinical StudySkin Pharmacology and Physiology, 1988
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987